The impact of loco-regional recurrences on metastatic progression in early-stage breast cancer: a multistate model
- 16 January 2009
- journal article
- research article
- Published by Springer Science and Business Media LLC in Breast Cancer Research and Treatment
- Vol. 117 (2), 401-408
- https://doi.org/10.1007/s10549-008-0300-2
Abstract
No abstract availableKeywords
This publication has 36 references indexed in Scilit:
- Impact on survival of early detection of isolated breast recurrences after the primary treatment for breast cancer: a meta-analysisBreast Cancer Research and Treatment, 2008
- Impact of a Higher Radiation Dose on Local Control and Survival in Breast-Conserving Therapy of Early Breast Cancer: 10-Year Results of the Randomized Boost Versus No Boost EORTC 22881-10882 TrialJournal of Clinical Oncology, 2007
- Age remains the first prognostic factor for loco-regional breast cancer recurrence in young (<40 years) women treated with breast conserving surgery firstRadiotherapy and Oncology, 2007
- An overview of prognostic factors for long-term survivors of breast cancerBreast Cancer Research and Treatment, 2007
- Tutorial in biostatistics: competing risks and multi‐state modelsStatistics in Medicine, 2006
- The prognosis of patients with local recurrence more than five years after breast conservation therapy for invasive breast carcinomaEuropean Journal of Surgical Oncology, 2006
- Twenty-Year Follow-up of a Randomized Study Comparing Breast-Conserving Surgery with Radical Mastectomy for Early Breast CancerNew England Journal of Medicine, 2002
- Improved survival after one course of perioperative chemotherapy in early breast cancer patients: long-term results from the European Organization for Research and Treatment of Cancer (EORTC) Trial 10854European Journal of Cancer, 2001
- Prognostic factors for survival after breast conserving therapy for stage I and II breast cancer. The role of local recurrenceEuropean Journal of Cancer, 1995
- Factors influencing local relapse and survival and results of salvage treatment after breast-conserving therapy in operable breast cancer: EORTC trial 10801, breast conservation compared with mastectomy in TNM stage I and II breast cancerEuropean Journal of Cancer, 1992